Olot

The registry focuses on patients with venous thromboembolism VTE, including those often excluded from typical clinical trials such as pregnant women, elderly patients, and those with serious health conditions. It aims to improve medical knowledge and patient care by collecting detailed data on these patients clinical status and treatment outcomes. The project also seeks to develop predictive scores to identify patients at higher risk of complications from thromboembolic disease. This observational registry collects extensive information on patients diagnosed with VTE, including details on coexisting conditions, antithrombotic treatment type, dose, and duration, as well as outcomes during the first three months of therapy. It captures data on VTE recurrences, bleeding complications, and deaths, providing insights into real-world treatment and patient management. Participants provide informed consent and are followed for at least three months to monitor clinical outcomes. The registry supports physicians by giving access to data on patients with similar profiles to help manage complex cases. The main outcomes measured include VTE events and complications over a three-year period, supporting ongoing improvements in patient care and risk assessment.

Researchers are evaluating an integrated home care program called ADMIT for older adults aged 70 or more who live at home and face complex health and social needs. The study aims to see if this multi-component intervention, which uses technology and coordinated care, can increase the percentage of days these individuals spend at home compared to usual care. Additional goals include reducing health crises, improving quality of life for patients and their caregivers, and assessing the programs cost-effectiveness and overall experience. Participants will be randomly assigned to either receive usual care or the ADMIT program, which is co-created by professionals, patients, and caregivers. The ADMIT program involves proactive candidate detection from health and social services, assignment of reference professionals from both sectors, shared diagnosis and individualized care plans, and ongoing shared follow-up. A technological platform supports communication and information sharing among all parties, with optional use of sensors and robotic devices to assist home care. During the six-month intervention, researchers will track the percentage of days participants spend at home, monitor health and social crises, and gather feedback on experiences from patients, caregivers, and professionals. The study uses mixed methods to evaluate effectiveness, safety, and cost-utility in real-world settings, with an overall goal to support aging individuals in their homes while improving care quality and system sustainability.